{
  "retracted": false,
  "timestamp": 1591833600000,
  "updates": [
    {
      "timestamp": 1591868426833,
      "identifier": {
        "doi": "10.1186/s40545-020-00231-5"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1186/s40545-020-00219-1"
  },
  "journal": "Journal of Pharmaceutical Policy and Practice",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety"
}
